Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Oxford, United Kingdom
Countries of investment
  • United Kingdom
Investment stages
  • Seed
  • Series A
Industries
  • Digital Health
  • Software
About
Oxford Capital focuses on investing in early-stage technology startups based in the UK. The firm prioritizes companies with clear unit economics, experienced founding teams, and a roadmap for scalable growth. Oxford Capital combines capital with strategic support, providing disciplined follow-on investment to ensure that portfolio companies can move from seed to growth stages. The firm’s focus is on helping these companies scale efficiently while maintaining strong financial discipline.
Min check size
$100K
Max check size
$20M
Fund size
NPS

Investment Thesis

Oxford Capital’s investment thesis focuses on early-stage UK technology companies with scalable growth models and disciplined capital use. It seeks ventures with proven traction, strong management, and defensible IP, providing capital and follow-on support to accelerate them through growth stages.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Experienced investment team with strong roots in technology and innovation sectors, supporting early to growth stage companies in the UK.

Oxford Capital Contacts Information

Primary contact

Secondary contact

Team

David Mott – Founder Partner

Lucia Gunn – Director

Finance & Operations

Stephen Hampson – Investment Director

Giles Woodward – Compliance Officer

Hala Georgy – Portfolio Manager

James Stothard – Senior Manager

Marketing & Communications

Nick Sudlow – Manager

Investor Relations

Millie Feeney – Associate

Investor Relations

Antony Shaw – Senior Manager

Operations

Venkata Ramana Kolagotla – Salesforce Administrator

Jackson Price – Data Engineer

Elizabeth Morris – Manager

Finance & Operations

Edward Mott – Chair

David Van Oss – Non-Executive Director

James Witter – Non-Executive Director.

Portfolio

Ergodic

AI platform for decision‑making

embedded insurance

clinical stage immunotherapies

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp